CME proposes sale of 4,200 common shares

CME Group submitted a Form 144 reporting a proposed sale of common shares.

Rhea-AI Filing Summary

CME Group submitted a Form 144 reporting a proposed sale of common shares. The notice lists a broker, Morgan Stanley Smith Barney LLC, and an intended sale date of 02/23/2026. The filing itemizes equity awards: 218 performance stock units (03/15/2021), 3,285 performance stock units (03/15/2021) and 697 restricted shares (09/15/2019).

Insights

Securities Compliance Attorney

Form 144 documents a brokered proposed sale of listed common shares by an insider.

Form 144s serve as a notice of proposed sales under resale rules; this filing names Morgan Stanley Smith Barney LLC as the broker and cites an intended sale date of 02/23/2026. The itemized amounts—218, 3,285, and 697—are listed as award types with their original grant dates.

Execution, settlement, and exact proceeds depend on subsequent broker activity and sale confirmations; timing and cash‑flow treatment are not specified in the provided excerpt. Subsequent filings or broker reports would show completed sale details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CME's Form 144 report?

It reports a proposed resale of common shares through a broker. The filing lists Morgan Stanley Smith Barney LLC and an intended sale date of 02/23/2026, with specific equity award counts included.

How many equity awards are listed on the filing for CME?

The filing itemizes three award lines: 218 performance stock units, 3,285 performance stock units, and 697 restricted shares, each shown with its original grant date.

Does the Form 144 state how much cash CME will receive?

No dollar proceeds are stated in the provided excerpt. The notice lists share/unit counts and a broker, but it does not disclose sale proceeds or pricing in the excerpt.

Who is the broker handling the proposed sale in CME's Form 144?

The broker named is Morgan Stanley Smith Barney LLC, with address information included in the filing excerpt and the intended transaction linked to NASDAQ-listed common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:11 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001341363
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CME GROUP INC.
SEC File Number	001-31553
Address of Issuer	20 South Wacker Drive Chicago ILLINOIS 60606
Phone	(312) 930-1000
Name of Person for Whose Account the Securities are To Be Sold	BRYAN T DURKIN REVOCABLE TRUST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4200	1300519.50	360596647	02/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2021	Performance Stock Units	Issuer			218	03/15/2021	Services Rendered
Common	03/15/2021	Performance Stock Units	Issuer			3285	03/15/2021	Services Rendered
Common	09/15/2019	Restricted stock vesting under a registered plan	Issuer			697	09/15/2019	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/23/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Bryan Durkin, Trustee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)